Published in TB and Outbreaks Week, December 18th, 2001
The patented technology was a major breakthrough in working with an important class of molecular compounds called oxazolidonones, which have shown tremendous activity against highly resistant bacteria. Oxazolidonones were used to develop Zyvox, which is the most effective drug on the market today to treat...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week